Catheter ablation

Catheter ablation has been studied in 61 papers since 2016: 3 trials and 25 observational studies in people, 32 reviews; 32 in the past year. The newest story, Oct 26, 2026: “Heart procedure linked to fewer strokes and deaths at 80 and older”.

Intervention

61 papers study it53 findingsUpdated

MeSH

11 new papers in 30 daysSee all 61 papers on catheter ablation

At a glance

Independent labs found the same change in people. 17 independent labs in 8 countries.

“Compared with drug therapy, catheter ablation did not significantly reduce the risk of clinical outcomes, with no significant difference observed across frailty strata.”
Effects of ablation versus drug therapy on clinical outcomes and quality of life by frailty status in atrial fibrillation: a post hoc analysis of the CABANA trialBMC medicine2026doi:10.1186/s12916-026-04676-4

3 of its findings point the other way.

Humans: replicated by independent labs. Cells, worms or flies and mice: nothing yet.
  • 17 independent labs in 8 countries
  • 3 findings against
  • Funders: National Heart, Lung, and Blood Institute and others
  • 10 of 44 findings with company ties
  • Human trial3
  • Humans25

Studies in people

1 study gave catheter ablation to people and measured what changed.

What changedDesignPeopleSource

no change: Has no effect on composite of death, disabling stroke, serious bleeding, or cardiac arrestHR 0.85, 95% CI 0.64–1.14

down: Decreases MAFSI frequency score-1.58 points, 95% CI -2.11 to -1.06

no change: Has no effect on quality of life

Randomized trialmedian follow-up of 1440 days2,189 peopleaged ≥ 65 or < 65 years with ≥ 1 risk factor for strokeSymptomatic and inadequately treated patients with AFBMC medicine, Feb 7, 2026

What did studies of catheter ablation find?

19

Studies of catheter ablation measured 19 outcomes; the most studied are mortality (4 studies) and quality of life (2).

Mortality

downin humans4HR 0.32–0.58

4 studies
  1. Catheter ablation is linked with lower mortality in humans (older adults with AF) (HR 0.58, 95% CI: 0.55-0.61).

    Humansolder adults with AF59% males

  2. Catheter ablation is linked with lower mortality in humans (nonvalvular atrial fibrillation, using direct oral anticoagulants) (3.0% vs. 7.8%, HR 0.32 (95% CI 0.16-0.88)).

    Humansnonvalvular atrial fibrillation, using direct oral anticoagulants3 years

  3. Catheter ablation decreases mortality in humans (atrial fibrillation with HFpEF).

    Reviewatrial fibrillation with HFpEF

  4. Catheter ablation decreases mortality in humans (paroxysmal and persistent atrial fibrillation).

    Reviewparoxysmal and persistent atrial fibrillation

Quality of life

upin humans1no changein humans1

2 studies
  1. Catheter ablation showed no clear effect on quality of life in humans among patients with non-frailty.

    Human trialamong patients with non-frailtymedian follow-up of 1440 daysn = 737

  2. Catheter ablation improves quality of life in humans (heart failure with preserved ejection fraction and atrial fibrillation).

    Reviewheart failure with preserved ejection fraction and atrial fibrillation

MAFSI frequency score

downin humans1

1 study
  1. Catheter ablation decreases MAFSI frequency score in patients with AF and frailty (-1.58 points, 95% CI -2.11 to -1.06).

    Human trialin patients with AF and frailtymedian follow-up of 1440 daysn = 1,452

  2. Catheter ablation decreases MAFSI frequency score in patients with AF and frailty.

    Human trialin patients with AF and frailty

Composite of death, disabling stroke, serious bleeding, or cardiac arrest

no changein humans1HR 0.85

1 study
  1. Catheter ablation showed no clear effect on composite of death, disabling stroke, serious bleeding, or cardiac arrest in the overall cohort (HR 0.85, 95% CI 0.64–1.14).

    Human trialin the overall cohortmedian follow-up of 1440 daysn = 2,189

  2. Catheter ablation showed no clear effect on composite of death, disabling stroke, serious bleeding, or cardiac arrest in humans across frailty strata.

    Human trialacross frailty strata

Montreal Cognitive Assessment score

no changein humans1upin humans1

1 study
  1. Catheter ablation showed no clear effect on montreal Cognitive Assessment score in humans (patients with atrial fibrillation; subgroup analysis) (WMD 1.20, 95% CI -0.19–2.58).

    Reviewpatients with atrial fibrillation; subgroup analysis< 3 months

  2. Catheter ablation improves montreal Cognitive Assessment score in humans (patients with atrial fibrillation) (WMD 1.00, 95% CI 0.36–1.64).

    Reviewpatients with atrial fibrillation

Modified Rankin Scale

upin humans1

1 study
  1. Catheter ablation is linked with better modified Rankin Scale in humans (patients with AF and a history of ischemic stroke) (aOR 0.31 (95% CI 0.19-0.51)).

    Humanspatients with AF and a history of ischemic strokemedian follow-up 3.0 yearsn = 250

    Early ablation is linked to lower cardiovascular risk after stroke

    Neurology

More on Modified Rankin Scale

Cerebral infarction

no changein humans1

1 study
  1. Catheter ablation was not clearly linked with cerebral infarction in humans (patients with atrial fibrillation undergoing ablation).

    Humanspatients with atrial fibrillation undergoing ablationbrainwithin 48 hoursn = 75

More on Cerebral infarction

Remedes for Alzheimer

upin humans1

1 study
  1. Catheter ablation is linked with better remedes for Alzheimer in humans (patients with atrial fibrillation) (mean difference in change score, 3.18 (95% CI, 0.87 to 5.49)).

    Humanspatients with atrial fibrillationbrain6 months

More on Remedes for Alzheimer

Montreal Cognitive Assessment

upin humans1

1 study
  1. Catheter ablation is linked with better Montreal Cognitive Assessment in humans (patients with atrial fibrillation) (mean difference in change, 0.74 (95% CI, 0.17 to 1.31)).

    Humanspatients with atrial fibrillationbrain6 months

More on Montreal Cognitive Assessment

Hippocampal volume

upin humans1

1 study
  1. Catheter ablation is linked with higher hippocampal volume in humans (atrial fibrillation; compared with drug therapy) (+0.1% versus -1.0%; P = 0.043).

    Humansatrial fibrillation; compared with drug therapyhippocampus6 monthsn = 51

All 19

What is catheter ablation linked with?

15

Studies link catheter ablation with 15 measures, most often dementia (9 studies), mortality (3) and Alzheimer's disease (2).

Dementia

downin humans9HR 0.52–0.74

9 studies
  1. Catheter ablation is associated with dementia in humans (Atrial fibrillation; early versus intermediate ablation, after propensity score matching) (HR 0.74, 95% CI 0.49–1.12).

    HumansAtrial fibrillation; early versus intermediate ablation, after propensity score matchingwithin 1 year of diagnosis3 yearsn = 12,146

  2. Catheter ablation is linked with a lower risk of dementia in humans (older adults with AF) (HR 0.52, 95% CI: 0.45-0.61).

    Humansolder adults with AF59% males

  3. Catheter ablation is associated with dementia in humans (patients with atrial fibrillation; compared with anti-arrhythmic drugs alone) (41% lower risk; 1.9% vs 3.3%; HR 0.59, 95% CI 0.52-0.67).

    Humanspatients with atrial fibrillation; compared with anti-arrhythmic drugs alone

  4. Catheter ablation lowers the risk of dementia in humans (registry studies).

    Reviewregistry studies

  5. Catheter ablation lowers the risk of dementia in humans (HR 0.52–0.69).

    Review

  6. Catheter ablation lowers the risk of dementia in patients with AF (HR 0.62; 95% CI 0.56-0.68).

    Reviewin patients with AF

  7. Catheter ablation is associated with dementia in humans (patients with atrial fibrillation; compared with the nonablation group) (HR 0.63, 95% CI 0.52–0.77; P < 0.001).

    Reviewpatients with atrial fibrillation; compared with the nonablation groupn = 125,649

  8. Catheter ablation is associated with dementia in humans (patients with atrial fibrillation; compared with no ablation) (HR 0.60, 95% CI 0.43–0.84).

    Reviewpatients with atrial fibrillation; compared with no ablation

  9. Catheter ablation is associated with dementia in humans (atrial fibrillation).

    Reviewatrial fibrillation

More on Dementia

Mortality

downin humans3HR 0.36–0.51

3 studies
  1. Catheter ablation is associated with mortality in humans (Paroxysmal atrial fibrillation; compared with a procedurally eligible control cohort) (2.97% vs. 8.05%; HR 0.36, 95% CI 0.25–0.52).

    HumansParoxysmal atrial fibrillation; compared with a procedurally eligible control cohort90 days to 1 year

    Heart procedure linked to fewer strokes and deaths at 80 and older

    ESC Congress 2026 abstract
  2. Catheter ablation is associated with mortality in humans (patients with atrial fibrillation; compared with anti-arrhythmic drugs alone) (49% lower risk; HR 0.51, 95% CI 0.46-0.55).

    Humanspatients with atrial fibrillation; compared with anti-arrhythmic drugs alone

  3. Catheter ablation is associated with mortality in humans (patients with atrial fibrillation).

    Reviewpatients with atrial fibrillation

Alzheimer's disease

downin humans2HR 0.78–0.83

2 studies
  1. Catheter ablation is associated with Alzheimer's disease in humans (Atrial fibrillation; early versus intermediate ablation, after propensity score matching) (HR 0.83, 95% CI 0.45–1.53).

    HumansAtrial fibrillation; early versus intermediate ablation, after propensity score matchingwithin 1 year of diagnosis3 yearsn = 12,146

  2. Catheter ablation is associated with Alzheimer's disease in humans (patients with atrial fibrillation; compared with the non-CA group) (HR 0.78, 95% CI 0.66–0.92; P < 0.001).

    Reviewpatients with atrial fibrillation; compared with the non-CA group

More on Alzheimer's disease

Cognitive impairment

downin humans2

2 studies
  1. Catheter ablation is linked with a lower risk of cognitive impairment in humans (patients with AF and a history of ischemic stroke) (aOR 0.42 (95% CI 0.24-0.72)).

    Humanspatients with AF and a history of ischemic strokemedian follow-up 3.0 yearsn = 250

    Early ablation is linked to lower cardiovascular risk after stroke

    Neurology
  2. Catheter ablation is linked with a lower risk of cognitive impairment in humans (atrial fibrillation) (aOR 0.70, 95% CI 0.50-0.97).

    Humansatrial fibrillation2-yearn = 887

Cognitive test performance

upin humans1

1 study
  1. Catheter ablation is associated with cognitive test performance in humans (Hedges g 0.70, 95% CI 0.11–1.30; p = 0.021).

    ReviewAdults with atrial fibrillation and no baseline dementia; compared with medical rhythm controlLongest follow-up: 104 weeksn = 1,247

De novo ischemic stroke

downin humans1HR 0.466

1 study
  1. Catheter ablation is associated with de novo ischemic stroke in humans (Paroxysmal atrial fibrillation without prior stroke) (1.49% vs. 3.13%; HR 0.466, 95% CI 0.26–0.84).

    HumansParoxysmal atrial fibrillation without prior stroke90 days to 1 year

    Heart procedure linked to fewer strokes and deaths at 80 and older

    ESC Congress 2026 abstract

More on De novo ischemic stroke

Ischemic stroke

downin humans1HR 0.52

1 study
  1. Catheter ablation is associated with ischemic stroke in humans (Paroxysmal atrial fibrillation; compared with a procedurally eligible control cohort) (3.86% vs. 7.30%; HR 0.52, 95% CI 0.37–0.72).

    HumansParoxysmal atrial fibrillation; compared with a procedurally eligible control cohort90 days to 1 year

    Heart procedure linked to fewer strokes and deaths at 80 and older

    ESC Congress 2026 abstract

More on Ischemic stroke

Cardiovascular rehospitalization

downin humans1

1 study
  1. Catheter ablation is linked with a lower risk of cardiovascular rehospitalization in humans (patients with AF and a history of ischemic stroke) (absolute difference 11.98% (95% CI 2.26%-21.44%)).

    Humanspatients with AF and a history of ischemic stroke36 monthsn = 431

    Early ablation is linked to lower cardiovascular risk after stroke

    Neurology

Major adverse cardiovascular events

downin humans1

1 study
  1. Catheter ablation is linked with a lower risk of major adverse cardiovascular events in humans (patients with AF and a history of ischemic stroke) (ARR 11.17% (95% CI 5.81%-17.36%)).

    Humanspatients with AF and a history of ischemic stroke36 monthsn = 431

    Early ablation is linked to lower cardiovascular risk after stroke

    Neurology

Cognitive dysfunction

downin humans1

1 study
  1. Catheter ablation lowers the risk of cognitive dysfunction in humans (compared to rate control in atrial fibrillation patients) (27%-30% lower risk).

    Reviewcompared to rate control in atrial fibrillation patients

More on Cognitive dysfunction

All 15

Funding

3 grants since 2019

National Heart, Lung, and Blood Institute$2MJapan Society for the Promotion of Science¥4.2MAmerican Heart Association$300K

Latest

Dec 2025: 0Jan 2026: 6Feb 2026: 5Mar 2026: 4Apr 2026: 1May 2026: 1Jun 2026: 0Jul 2026: 2Aug 2026: 0Sep 2026: 0Oct 2026: 9Nov 2026: 331 papers in 12 months
ESC Congress 2026 Abstract

Heart procedure linked to fewer strokes and deaths at 80 and older

Between 90 days and one year after ablation, stroke rates were 3.86% versus 7.30% in controls; death rates were 2.97% versus 8.05%.Between 90 days and one year after ablation, stroke rates were 3.86% versus 7.30% in controls; death rates were 2.97% versus 8.05%.

Cohort studyInterventions

See all 61 papers on catheter ablation